Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents.

Cancer Discovery
Nicolai J BirkbakAndrea L Richardson

Abstract

DNA repair competency is one determinant of sensitivity to certain chemotherapy drugs, such as cisplatin. Cancer cells with intact DNA repair can avoid the accumulation of genome damage during growth and also can repair platinum-induced DNA damage. We sought genomic signatures indicative of defective DNA repair in cell lines and tumors and correlated these signatures to platinum sensitivity. The number of subchromosomal regions with allelic imbalance extending to the telomere (N(tAI)) predicted cisplatin sensitivity in vitro and pathologic response to preoperative cisplatin treatment in patients with triple-negative breast cancer (TNBC). In serous ovarian cancer treated with platinum-based chemotherapy, higher levels of N(tAI) forecast a better initial response. We found an inverse relationship between BRCA1 expression and N(tAI) in sporadic TNBC and serous ovarian cancers without BRCA1 or BRCA2 mutation. Thus, accumulation of telomeric allelic imbalance is a marker of platinum sensitivity and suggests impaired DNA repair. Mutations in BRCA genes cause defects in DNA repair that predict sensitivity to DNA damaging agents, including platinum; however, some patients without BRCA mutations also benefit from these agents. NtAI, a g...Continue Reading

References

May 31, 2001·Nature Genetics·H Vrieling
Aug 31, 2002·Genes, Chromosomes & Cancer·Elena KolomietzJeremy A Squire
Apr 25, 2003·Cancer·Ilana CassBeth Y Karlan
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Therese SorlieDavid Botstein
Dec 9, 2003·The Breast : Official Journal of the European Society of Mastology·Keith N OgstonSteven D Heys
Jun 10, 2004·British Journal of Cancer·S BamfordR Wooster
Jul 16, 2004·Molecular and Cellular Biology·Martin F ArltThomas W Glover
Jul 27, 2004·Science·Jonathan SebatMichael Wigler
Aug 3, 2004·Nature Genetics·A John IafrateCharles Lee
Jul 22, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sunil R LakhaniUNKNOWN Breast Cancer Linkage Consortium
Feb 14, 2006·Cancer Cell·Andrea L RichardsonShridar Ganesan
Oct 4, 2006·Oncogene·N C TurnerA N Tutt
Mar 14, 2007·Cell·Daniel P SilverDavid M Livingston
Feb 12, 2008·Nature·Stacey L EdwardsAlan Ashworth
Apr 17, 2008·Cancer Research·Elizabeth M SwisherToshiyasu Taniguchi
Jul 24, 2008·Breast Cancer Research and Treatment·T ByrskiS A Narod
Aug 30, 2008·Genome Dynamics·R KalbH Hoehn
Dec 5, 2008·Microbiology and Molecular Biology Reviews : MMBR·Guy-Franck RichardBernard Dujon
Jul 15, 2009·Nature Reviews. Genetics·P J HastingsGrzegorz Ira
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel P SilverJudy E Garber
Mar 24, 2010·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Gil McVean
May 11, 2010·Nature Structural & Molecular Biology·Peter BouwmanJos Jonkers
Sep 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Peter Van LooVessela N Kristensen
Jan 22, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Herman BurgerErik A C Wiemer
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
Oct 18, 2011·Proceedings of the National Academy of Sciences of the United States of America·Laura M HeiserPaul T Spellman
Dec 17, 2011·BMC Bioinformatics·Qiyuan LiAron C Eklund

❮ Previous
Next ❯

Citations

Jul 31, 2012·Cancer Discovery·Daniel P Silver, David M Livingston
Nov 23, 2013·PloS One·Nicolai Juul BirkbakZhigang C Wang
Aug 6, 2014·Breast Cancer Research : BCR·Johnathan A WatkinsAndrew N J Tutt
Sep 17, 2013·Oncogene·J MichelsG Kroemer
Sep 1, 2015·International Journal of Cancer. Journal International Du Cancer·Elodie ManiéMarc-Henri Stern
Jan 19, 2016·Nature Reviews. Cancer·Christopher J Lord, Alan Ashworth
Mar 5, 2016·Current Treatment Options in Oncology·Fong W Liu, Krishnansu S Tewari
Nov 6, 2015·Trends in Pharmacological Sciences·Murugan KalimuthoKum Kum Khanna
Mar 10, 2016·Cancer Metastasis Reviews·Christine DesmedtJanina Kulka
Mar 12, 2016·Critical Reviews in Oncology/hematology·Nicolas De PicciottoS Intidhar Labidi-Galy
Aug 10, 2015·The Breast : Official Journal of the European Society of Mastology·Daniel G Stover, Eric P Winer
Feb 13, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T Helleday
Mar 18, 2016·Current Oncology Reports·Joyce F Liu, Ursula A Matulonis
Oct 12, 2013·The Journal of Pathology·Brian D Lehmann, Jennifer A Pietenpol
Apr 22, 2015·International Journal of Cancer. Journal International Du Cancer·Oumou GoundiamXavier Sastre-Garau
Feb 20, 2016·Expert Review of Molecular Diagnostics·Ben Davidson
Apr 8, 2015·Breast Cancer Research : BCR·Balázs GyőrffyLajos Pusztai
May 27, 2015·Breast Cancer Research and Treatment·Virginia G KaklamaniWilliam Gradishar
Jul 23, 2014·Breast Cancer Research and Treatment·Aleix PratJudith Balmaña
Mar 25, 2014·Current Opinion in Genetics & Development·Rebecca A Burrell, Charles Swanton
Jan 15, 2015·Cancer Cell·Nicholas McGranahan, Charles Swanton
Jan 9, 2015·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Melinda L Telli, George W Sledge
Oct 19, 2016·Nature Reviews. Clinical Oncology·Giampaolo BianchiniLuca Gianni
Jun 4, 2016·Molecular Cell·Elizabeth M KassMaria Jasin
Jun 28, 2016·Cancer Treatment Reviews·L GerratanaF Puglisi
May 27, 2016·Endocrine-related Cancer·Diana Lim, Joanne Ngeow
Aug 25, 2016·Hereditary Cancer in Clinical Practice·Aglaya G Iyevleva, Evgeny N Imyanitov
Aug 16, 2016·European Journal of Human Genetics : EJHG·Dominique Stoppa-Lyonnet
Apr 29, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip C Schouten, Sabine C Linn
Mar 18, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Clare L ScottScott H Kaufmann
Jan 7, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nadine M Tung, Eric P Winer
Mar 25, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jia-Min B PangStephen B Fox
Mar 17, 2017·Expert Opinion on Pharmacotherapy·Yada KanjanapanAmit M Oza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Zhigang C WangUrsula A Matulonis
Proceedings of the National Academy of Sciences of the United States of America
Peter Van LooVessela N Kristensen
© 2021 Meta ULC. All rights reserved